These data support the notion that HGF is primarily produced in stromal tissue in breast cancers and therefore studying the role of HGF/Met signaling using cell culture models may overlook important contributions of the tumor microenvironment to EGFR/Met crosstalk in breast cancer. Here, EGFR is linked to breast carcinoma.